Literature DB >> 2481433

Identification and partial purification of the fusion protein of avian paramyxovirus type 3.

C L Anderson1, P H Russell.   

Abstract

The fusion protein of an avian paramyxovirus-3 from turkeys was detected as a poorly-labelled 56K 3H-glucosamine band. After immunopurification by a monoclonal antibody it elicited antisera which inhibited haemolysis but not haemagglutination.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2481433     DOI： 10.1007/bf01310942

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  7 in total

1.  Association of soluble matrix protein of Newcastle disease virus with liposomes is independent of ionic conditions.

Authors:  K S Faaberg; M E Peeples
Journal:  Virology       Date:  1988-09       Impact factor: 3.616

2.  Isolation of avian paramyxovirus other than Newcastle disease virus from commercial poultry in Great Britain.

Authors:  I Macpherson; R G Watt; D J Alexander
Journal:  Vet Rec       Date:  1983-05-14       Impact factor: 2.695

3.  The structural polypeptides of avian paramyxoviruses.

Authors:  D J Alexander; M S Collins
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

4.  Cleavability of hemagglutinin determines spread of avian influenza viruses in the chorioallantoic membrane of chicken embryo.

Authors:  R Rott; M Reinacher; M Orlich; H D Klenk
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

5.  Characterisation of avian paramyxoviruses of serotype PMV-3 isolated from commercial turkeys in Great Britain.

Authors:  D J Alexander; M S Collins
Journal:  Avian Pathol       Date:  1984-04       Impact factor: 3.378

6.  A hitherto unreported paramyxovirus of turkeys.

Authors:  B Tumova; J H Robinson; B C Easterday
Journal:  Res Vet Sci       Date:  1979-09       Impact factor: 2.534

7.  Monoclonal antibodies against avian paramyxovirus-3: antigenic mapping and functional analysis of the haemagglutinin-neuraminidase protein and the characterization of nonspecific monoclonal antibodies.

Authors:  C L Anderson; P H Russell
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.